Hansoh BioMedical

Hansoh BioMedical is the United States-based research and development arm of Hansoh Pharmaceutical Group, one of China's leading innovation-driven pharmaceutical companies. The company focuses on discovering and developing novel therapeutics for oncology, metabolic disorders, central nervous system diseases, and anti-infectives. Hansoh BioMedical leverages advanced technology platforms, particularly in antibody-drug conjugates (ADCs) and siRNA, to create a robust pipeline of clinical-stage candidates. With a significant presence in both China and the U.S., the company actively pursues global clinical development and strategic partnerships with major pharmaceutical firms to address unmet medical needs worldwide.